U.S. Health Secretary Robert F. Kennedy Jr. announced plans to reform the National Vaccine Injury Compensation Program (VICP), pledging to address what he calls inefficiencies and corruption within the system. Kennedy, a long-time vaccine skeptic and former vaccine injury lawyer, criticized the program’s “Vaccine Court” for failing to quickly and fairly compensate individuals harmed by vaccines.
In a post on X, Kennedy said he is working with Attorney General Pam Bondi to restore the program to its “original congressional intent,” arguing that its current structure unfairly positions the Department of Health and Human Services (HHS), which he leads, as the defendant rather than vaccine manufacturers.
This move continues Kennedy’s sweeping efforts to reshape U.S. vaccine and health policy. In June, he dismissed all 17 members of the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices, replacing them with seven appointees, including figures with histories of questioning vaccine safety. One of these members previously earned significant fees as an expert witness against Merck’s Gardasil vaccine, a case in which Kennedy played a key role.
Kennedy is also reportedly considering removing members of another influential health advisory panel, the U.S. Preventive Services Task Force. His tenure at HHS has intensified scrutiny due to his longstanding promotion of vaccine skepticism, including discredited claims linking vaccines to autism and false statements about fetal cells in the measles vaccine.
The announcement comes amid one of the worst U.S. measles outbreaks in decades, further fueling debate over vaccine safety, public health policy, and Kennedy’s leadership approach.


Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
YouTube Agrees to Follow Australia’s New Under-16 Social Media Ban
U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits
U.S. Halts Visa Processing for Afghan Nationals Amid Security Concerns
Flights Briefly Grounded at Philadelphia International Airport After Bomb Threat Resolved
Putin Concludes High-Level Talks With Trump Envoy on Ending Ukraine Conflict
U.S.–Russia Peace Talks Stall as Kremlin Rejects Key Proposals
Trump Administration Tightens H-1B Visa Vetting With New Focus on Free Speech and Censorship
Mexico Probes Miss Universe President Raul Rocha Over Alleged Criminal Links
Innovent’s Xinermei Intensifies Weight-Loss Drug Battle in China
U.S. to Reduce Import Duties on South Korean Autos Under New Trade Agreement
New Orleans Immigration Crackdown Sparks Fear as Federal Arrests Intensify
Novartis to Acquire Avidity Biosciences for $12 Billion to Strengthen Rare Muscle Disorder Portfolio
Trump Calls for Permanent Pause on Migration After National Guard Shooting Near White House
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Apple Alerts EU Regulators That Apple Ads and Maps Meet DMA Gatekeeper Thresholds 



